Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Bold refers to %Comparison of Low bone mass risk factors in fractured and non-fractured OI patientsFracturesN = 12No fractureN = 38pSmoking (%)2/12 (16.7)10/29 (34.5)0.45BMI < 19 kg/m2 (%)2/10 (20)2/29 (6.9)0.27Corticosteroids (%)01/29 (3.4)1Osteoporosis inducing diseaseSpondyloarthritis1/12 (8.3)00.2Inflammatory bowel disease1/12 (8.3)00.2Anorexia1/12 (8.3)1/29 (3.4)0.50Rheumatoid arthritis01/29 (3.4)1.0Immobilization3/10 (30.0)3/29 (10.3)0.1625OHD < 30 ng/ml (%)2/10 (20.0)13/27 (48.1)0.15Low calcium intake (%)1/12 (8.3)1/29 (3.4)0.50Spine BMD (Z-score)− 2.93 ± 1.57− 1.48 ± 1.670.03Femoral neck BMD (Z-score)− 2.25 ± 0.90− 0.7 ± 1.190.09Total hip BMD (Z-score)− 2.05 ± 0.74− 0.53 ± 1.360.04At least 1 risk factor, %9/11 (81.8)17/29 (58.6)0.2725OHD: 25-hydroxyvitamin D; BMD: Bone mineral density;Comparison of Pregnancy and lactation-related factors in fractured and non-fractured OI patientsFracturesN = 12No fractureN = 38pAge (years; mean ± SD)32.7 ± 3.129.3 ± 5.00.002Number of pregnancies (mean ± SD)0.5 ± 0.90.6 ± 0.80.6Time since last pregnancy (years, mean ± SD)4.1 ± 2.74.4 ± 2.00.51Duration of lactation after previous pregnancy (months, mean ± SD)5.5 ± 8.62.55 ± 4.80.86Breastfeeding (yes, %)*12/14 (85.7%)Including 100% of patients with post-partum fractures25/53 (47.1%)0.03* For pregnancy-related factors, data presented are the number of occurrence of each variable (e.g. breastfeeding) on the total number of pregnancies in each group
Source: Clinical characteristics comparison of fractured and non-fractured OI patients (Tables 3, 4, 5). View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
We performed a retrospective cohort study including women with a clinical diagnosis of OI assessed in Rheumatology department, Cochin Hospital, between January 2006 and December 2019.
Source: Methods.
Among the 63 women identified, 4 patients were excluded because they actually had other genetic causes of bone fragility (osteoporosis-pseudoglioma, and other rare bone diseases), and 9 were excluded because of insufficient data.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partum
Cohort study · Orphanet Journal of Rare Diseases · 2022
Original publication title
Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partum
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Pregnancy and breastfeeding are associated with bone density loss. Fracture occurrence during pregnancy and post-partum, and its determinants, remain poorly known in Osteogenesis Imperfecta (OI). The aim of this study was to characterize fractures that occurred during pregnancy and post-partum in OI patients.
Source: BackgroundAbstract: Results
We conducted a retrospective multicentric study including a total of 50 previously pregnant OI women from 10 Bone Centers in France. Among these patients, 12 (24%) patients experienced fractures during pregnancy or in the 6 months following delivery, and 38 (76%) did not experience any fracture. The most frequent localizations were: proximal femur (25%), spine (25%), distal femur (12.5%), and pelvis (12.5%). Fractures during pregnancy occurred during the third trimester and post-partum fractures occurred with a mean delay of 2 months following delivery.
No fractures occurred during childbirth.
We next compared the 12 patients with pregnancy or post-partum fractures with the 38 patients without fractures. Mean age at pregnancy was 32.7 ± 3.1 years-old in the fractured group, vs 29.3 ± 5.0 years-old in the non-fractured group (p = 0.002). Breastfeeding was reported in 85.7% of patients in the fractured group, vs 47.1% in the non-fractured group (p = 0.03). All patients with post-partum fractures were breastfeeding. Bone mineral density was significantly lower in patients with pregnancy-related fractures compared with other patients: spine Z-score − 2.9 ± 1.6DS vs − 1.5 ± 1.7DS (p = 0.03), and total hip Z-score − 2.0 ± 0.7DS vs − 0.5 ± 1.4DS (p = 0.04).
At least one osteoporosis-inducing risk factor or disease other than OI was identified in 81.8% vs 58.6% of fractured vs non-fractured patients (not significant). Fracture during pregnancy or post-partum was not associated with the severity of OI. Bisphosphonates before pregnancy were reported in 16.7% and 21.1% of patients with pregnancy-related fractures and non-fractured patients, respectively (not significant).
Source: Results Source: ResultsAbstract: Conclusions
OI management during pregnancy and post-partum should aim for optimal control of modifiable osteoporosis risk factors, particularly in patients with low BMD. Breastfeeding should be avoided.
Source: ConclusionsAuthors’ abstract
Background
Pregnancy and breastfeeding are associated with bone density loss. Fracture occurrence during pregnancy and post-partum, and its determinants, remain poorly known in Osteogenesis Imperfecta (OI). The aim of this study was to characterize fractures that occurred during pregnancy and post-partum in OI patients.
Results
We conducted a retrospective multicentric study including a total of 50 previously pregnant OI women from 10 Bone Centers in France. Among these patients, 12 (24%) patients experienced fractures during pregnancy or in the 6 months following delivery, and 38 (76%) did not experience any fracture. The most frequent localizations were: proximal femur (25%), spine (25%), distal femur (12.5%), and pelvis (12.5%). Fractures during pregnancy occurred during the third trimester and post-partum fractures occurred with a mean delay of 2 months following delivery.
No fractures occurred during childbirth.
We next compared the 12 patients with pregnancy or post-partum fractures with the 38 patients without fractures. Mean age at pregnancy was 32.7 ± 3.1 years-old in the fractured group, vs 29.3 ± 5.0 years-old in the non-fractured group (p = 0.002). Breastfeeding was reported in 85.7% of patients in the fractured group, vs 47.1% in the non-fractured group (p = 0.03). All patients with post-partum fractures were breastfeeding. Bone mineral density was significantly lower in patients with pregnancy-related fractures compared with other patients: spine Z-score − 2.9 ± 1.6DS vs − 1.5 ± 1.7DS (p = 0.03), and total hip Z-score − 2.0 ± 0.7DS vs − 0.5 ± 1.4DS (p = 0.04).
At least one osteoporosis-inducing risk factor or disease other than OI was identified in 81.8% vs 58.6% of fractured vs non-fractured patients (not significant). Fracture during pregnancy or post-partum was not associated with the severity of OI. Bisphosphonates before pregnancy were reported in 16.7% and 21.1% of patients with pregnancy-related fractures and non-fractured patients, respectively (not significant).
Conclusions
OI management during pregnancy and post-partum should aim for optimal control of modifiable osteoporosis risk factors, particularly in patients with low BMD. Breastfeeding should be avoided.
Publication and source details
Original title: Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partum
Eugénie Koumakis; Valérie Cormier-Daire; Azeddine Dellal; Marc Debernardi; Bernard Cortet; Françoise Debiais; Rose-Marie Javier; Thierry Thomas; Nadia Mehsen-Cetre; Martine Cohen-Solal; Elisabeth Fontanges; Michel Laroche; Valérie Porquet-Bordes; Christian Marcelli; Alexandra Benachi; Karine Briot; Christian Roux; Catherine Cormier
Orphanet Journal of Rare Diseases · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T10:18:19.911687+00:00
DOI: 10.1186/s13023-021-02148-x · PMC8796450